Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoshiyuki Shibasaki
Observed names:
Shibasaki, Yoshiyuki,
Y. Shibasaki
Institution:
Otsuka (Japan)
Observed institutions:
Otsuka (Japan),
University of Tsukuba,
Saga University,
Kyoto University,
Saiseikai Kumamoto Hospital,
Pfizer (Japan),
Saiseikai Fukuoka General Hospital,
Tokyo General Hospital
show all 8
ORCID:
0009-0003-0434-541X
Observed ORCID:
0009-0003-0434-541X
OpenAlex ID:
A5045867835
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study
2016
·
Akihiko Asahina
, Takafumi Etoh
, et al.
·
The Journal of Dermatology
·
92
PDF
A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
2022
·
Fumihiko Sakai
, Koichi Hirata
, et al.
·
The Journal of Headache and Pain
·
55
PDF
Impact of changes in social anxiety on social functioning and quality of life in outpatients with schizophrenia: A naturalistic longitudinal study
2020
·
Takahiro Nemoto
, Takashi Uchino
, et al.
·
Journal of Psychiatric Research
·
35
PDF
Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan
2015
·
Isao Sakaida
, Koji Nakajima
, et al.
·
Journal of Gastroenterology
·
35
PDF
Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan
2023
·
Koichi Hirata
, Hiromi Sano
, et al.
·
BMC Neurology
·
24
PDF
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease
2021
·
Shigeo Horie
, Satoru Muto
, et al.
·
Clinical and Experimental Nephrology
·
24
PDF
Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure
2018
·
Koichiro Kinugawa
, Naoki Sato
, et al.
·
Circulation Journal
·
24
PDF
Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis
2016
·
Isao Sakaida
, Shuji Terai
, et al.
·
Journal of Gastroenterology
·
22
PDF
The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease
2019
·
Cem Simsek
, Murat Dogru
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
20
PDF
Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients
2022
·
Takao Takeshima
, Masami Nakai
, et al.
·
The Journal of Headache and Pain
·
16
PDF
Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan
2021
·
Satoru Muto
, Tadashi Okada
, et al.
·
Clinical and Experimental Nephrology
·
16
PDF
Real‐world hospital mortality of liver cirrhosis inpatients in Japan: a large‐scale cohort study using a medical claims database
2021
·
Hiroshi Yatsuhashi
, Hiromi Sano
, et al.
·
Hepatology Research
·
16
The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer
2018
·
Takao Ueno
, Sadamoto Zenda
, et al.
·
International Journal of Clinical Oncology
·
15
PDF
Axitinib in metastatic renal cell carcinoma: beyond the second-line setting
2017
·
Yoshiko Umeyama
, Yoshiyuki Shibasaki
, et al.
·
Future Oncology
·
14
Characteristics of patients who seek medical attention for headache and those who do not: cross-sectional survey and linked medical claims data analysis in Japan
2024
·
Hisaka Igarashi
, Hiromi Sano
, et al.
·
BMJ Open
·
12
Correction: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
2022
·
Fumihiko Sakai
, Koichi Hirata
, et al.
·
The Journal of Headache and Pain
·
9
PDF
Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study
2020
·
Shigeru Sugiyama
, Kazuo Sato
, et al.
·
Japanese Journal of Clinical Oncology
·
8
PDF
Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2023
·
Noboru Imai
, Yuki Isogai
, et al.
·
Neurology and Therapy
·
7
PDF
Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study
2021
·
Yuta Saito
, Junichiro Kizaki
, et al.
·
Japanese Journal of Ophthalmology
·
7
Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions
2023
·
Kenji Kashiwagi
, Kentaro Ouchi
, et al.
·
Japanese Journal of Ophthalmology
·
5
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
2023
·
Kazumasa Saigoh
, Takao Takeshima
, et al.
·
Journal of Pain Research
·
5
PDF
Assessment of minimum clinically important difference in symptoms and functionality of Japanese patients with major depressive disorder following inadequate response to antidepressants: a post hoc analysis of the long-term study of brexpiprazole augmentation therapy in Japanese patients with major depressive disorder
2025
·
Hikaru Hori
, Masako Shiosakai
, et al.
·
Frontiers in Psychiatry
·
4
A study to investigate the prevalence of headache disorders and migraine conducted using medical claims data and linked results from online surveys: post-hoc analysis of other headache disorders
2024
·
Takao Takeshima
, Koichi Hirata
, et al.
·
BMC Neurology
·
4
Construction of a Heart Failure Database Collating Administrative Claims Data and Electronic Medical Record Data to Evaluate Risk Factors for In-Hospital Death and Prolonged Hospitalization
2019
·
Kazuhisa Kodama
, Tomohiro Sakamoto
, et al.
·
Circulation Reports
·
4
PDF
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
2023
·
Kazumasa Saigoh
, Takao Takeshima
, et al.
·
Journal of Pain Research
·
3
PDF
Show more works
View as search
Works count:
64
Citation count:
482
H-index:
14
I10-index:
15
Year
Topic
Type